Silodosin showed no clear difference in cardiovascular adverse events compared with naftopidil (low certainty).
Silodosin probably leads to higher sexual adverse events compared with naftopidil (moderate certainty).
Silodosin showed no clear difference in cardiovascular adverse events compared with alfuzosin (low certainty).
Silodosin probably leads to higher sexual adverse events compared with alfuzosin (moderate certainty).
Silodosin showed no clear difference in treatment withdrawal due to any reason compared with placebo (low certainty).
It is very uncertain whether silodosin changes cardiovascular adverse events compared with placebo (very low certainty).
Silodosin probably leads to higher sexual adverse events compared with placebo (moderate certainty).
It is very uncertain whether silodosin changes treatment withdrawal due to any reason compared with tamsulosin (very low certainty).
Silodosin showed no clear difference in cardiovascular adverse events compared with tamsulosin (low certainty).
It is very uncertain whether LOD of one ovary (unilateral) changes miscarriage compared with LOD of both ovaries (bilateral) (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether LOD of one ovary (unilateral) changes live birth compared with LOD of both ovaries (bilateral) (very low certainty).
The review found no eligible studies for this question.
LOD of one ovary (unilateral) may leads to lower clinical pregnancy compared with LOD of both ovaries (bilateral) (low certainty).